ASND Q1 2026 Earnings EPS Misses Estimates as Ascendis Pharma Navigates Cost Pressures PDS Biotechnology Q1 2026 Earnings EPS Beat on Narrower Loss Clinical Progress in Focus PRH Q1 2026 Earnings Strong EPS Beat Amid Market Uncertainty RLX Technology Q1 2026 Earnings EPS Miss Amid Margin Pressures CIEN Q1 2026 Earnings EPS Surges Past Estimates Amid Strong Operational Performance CLDX Q1 2026 Earnings Clinicalstage biotech reports widerthanexpected loss as pipeline investment continues